相关实验视频
Updated: Jan 15, 2026
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
808
区域性TAU PET模式预测了早期症状性阿尔茨海默氏病的潜在域特异性认知衰退
Maura Malpetti1,2, Saima Rathore3, Leonardo Iaccarino3
1Department of Clinical Neurosciences, Cambridge University Hospitals NHS Trust, University of Cambridge, Herchel Smith Building, Forvie Site Robinson Way, Cambridge Biomedical Campus, CB2 0SZ, Cambridge, UK. mm2243@medschl.cam.ac.uk.
Alzheimer's research & therapy
|October 7, 2025
概括
区域性tau-PET模式预测早期阿尔茨海默病 (AD) 的认知衰退. 特定的tau-PET结合点与情节性记忆,语义记忆,语言和实践的更快下降相关,有助于个性化AD治疗策略.
科学领域:
- 神经成像和神经学 神经学
- 阿尔茨海默氏症疾病研究研究
- 认知神经科学 认知神经科学
背景情况:
- -PET结合模式是异质的,与认知表现和神经退行相关.
- 了解区域性tau-PET模式对于预测早期症状性阿尔茨海默病 (AD) 的认知衰退至关重要.
- 这项研究调查了基线tau-PET,以预测临床试验参与者轻度认知障碍 (MCI) 或轻度AD痴呆症的纵向认知衰退.
研究的目的:
- 评估基线tau-PET的区域模式是否预测特定认知领域的未来纵向衰退.
- 评估tau-PET结合模式与早期症状AD的认知衰退率之间的关联.
- 探索tau-PET作为个性化AD预后的精准医学工具的潜力.
主要方法:
- 731名粉样蛋白阳性参与者 (MCI或轻度AD痴呆症) 接受了flortaucipir F 18 PET (FTP-PET),MRI和神经心理测试.
- 认知评估被重复,并计算了情节性记忆,语义记忆,执行功能,语言和实践的年度下降率.
- 潜增长曲线建模和相关性分析确定了基线FTP-PET模式,MRI和认知衰退之间的关联.
主要成果:
- 不同的区域FTP-PET信号模式与特定领域的认知衰退年率有显著的关联.
- 较高的temporo-parietal FTP-PET SUVR预测了更快的情节性记忆衰退;较高的左前时SUVR预测了更快的语义记忆衰退.
- 额头-时间-PET模式预测语言衰退,而额头-双层模式预测实践衰退;执行功能显示有限的空间关联.
结论:
- 区域性tau-PET信号模式与MCI和早期AD痴呆症的特定领域认知衰退有关.
- 陶-PET成像显示承诺作为一个精确医学工具,用于预测个体认知衰退轨迹在早期症状AD.
- 这些发现支持使用tau-PET进行个性化风险分层和AD治疗规划.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:30Dementia
517
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
517
01:22Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822